Charles River Laboratories International Inc CRL

NYSE US Health Care Life Sciences Tools & Services

$292.84 ▼ -0.54% ($-1.60)

Index member: S&P 500

Open $293.19

Prev Close $294.44

Day Range $287.23 – $295.23

52W Range $144.26 – $303.31

Market Cap $14.06B

Beta 1.40

EPS (TTM) $-4.85

📋 Company Profile

Industry	Life Sciences Tools & Services
Sector	Health Care
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	2000-06-23
Shares Out.	48,170,000
Website	criver.com/ ↗
Phone	17812226000
Employees	19,700
Revenue	$1.00B
Gross Profit	$363.4M
Net Income	-$760,000
Free Cash Flow	$370.6M
Total Assets	$7.53B
Total Liabilities	$4.64B
Equity	$2.85B

About Charles River Laboratories International Inc

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.

Charles River Laboratories International Inc is a publicly traded company under the ticker symbol CRL on the NEW YORK STOCK EXCHANGE, INC., operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.